Mc Adam, LLC Eagle Pharmaceuticals, Inc. Transaction History

Mc Adam, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 10, 2018	SELL	$66.65 - $83.86 $6,665 - $8,386	-100 Closed	0 $0
Q2 2018 Aug 22, 2018	SELL	$51.25 - $76.62 $15,375 - $22,986	-300 Reduced 75.0%	100 $8,000
Q1 2018 Apr 24, 2018	BUY	$52.16 - $66.86 $20,864 - $26,744	400 New	400 $21,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.